Honey, I Shrunk the Molecules
August 22, 2023
Does microRNA-132 have therapeutic potential against Alzheimer’s disease?
2 min read
July 2023
Antibody drug conjugates have been hailed as “magic bullets” for years. Are they finally about to live up to the hype? Experts in our cover feature discuss. Also in this issue; we speak with Lubrizol, which won an Innovation Award for itssolubility-enhancing excipient Apisolex; learn about oligonucleotides from CatSci’s Nigel Richardson; and find out why new approaches are needed for antimicrobial resistance. We also sit down with Tirtha Chakraborty from Vor Bio and take a look at the top prospects in the cell and gene sector.
Afraid of Banality, Driven by Beauty
August 15, 2023
Sitting Down With … Tirtha Chakraborty, Chief Scientific Officer at Vor Bio, who admitted, “I generally don't seek out publicity, so it was rather surprising and humbling” to be featured on The Medicine Maker 2023 Power List.
5 min read
Discovery & Development
Drug Discovery
Research News
Regulation & Standards
Business & Trends
Small Molecules
A Call to Arms for Antimicrobial Resistance
August 3, 2023
Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price. We don’t have enough drugs to fight the superbugs.
13 min read
Getting Results Through Novel Solubility-Enhancing Excipients
July 21, 2023
Every innovation begins as an idea, but it takes partnerships to bring them to life. We speak with Senior Global Marketing Manager Joey Glassco, LLS Health, about the novel excipient Apisolex, which won our 2022 Innovation Awards.
7 min read
The ADHD Video Game – for Adults
July 17, 2023
In 2021, the FDA approved EndeavorRX to treat ADHD in children. Now, Akili Interactive has released a version for adults on the Apple App Store.
2 min read
Remote Controlled Chemo
July 10, 2023
Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors
3 min read
Discovery & Development
Drug Delivery
Drug Discovery
Research News
Formulation
Cell & Gene
Business & Trends
Revenge of the ADCs
June 26, 2023
Are antibody drug conjugates (ADCs) finally about to live up to the “magic bullet” hype in cancer treatment?
15 min read
Blisters of Mercy
May 23, 2023
Child exposure to pharmaceutical substances appears to be decreasing, but what more can packaging companies do to push the trend?
7 min read
Ode to the Microbe
May 8, 2023
Understanding the role of microbial fermentation in the supply of the DNA template, RNA polymerase, and enzymes used in purification of mRNA vaccines
4 min read
The ‘Tides are Turning
April 12, 2023
Oligonucleotides are a complex, but promising new modality in therapeutics, Director of New Modalities at CatSci Nigel Richardson explains why.
5 min read
To Be Precise
March 30, 2023
With more and better data comes new advances, specifically in our knowledge of individual genetics. Here, Neil Ward, VP PacBio, EMEA, explains how pharmacogenomics research will accelerate precision medicine initiatives.
3 min read
A Roadmap to Greener Pharma Logistics
February 27, 2023
Pharmaceutical logistics by its nature creates sustainability challenges. There are opportunities for improvement, however, across warehousing, transportation, and packaging activities.
10 min read
